Syros Pharmaceuticals (SYRS) PT Lowered to $12 at Roth Capital

August 13, 2018 10:39 AM EDT Send to a Friend

Roth Capital analyst Matt Koranda ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Syros Pharmaceuticals (SYRS) PT Lowered to $12 at Roth Capital

Member Login

Free News Feed